Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Luna Innovations Incorporated (LUNA)

  • Technical Exchange News
  • Jan. 07, 2025, 02:42 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Tempest Therapeutics Inc. (TPST)

  • Technical Exchange News
  • Jan. 06, 2025, 19:17 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Luna Innovations Incorporated (LUNA)

  • Technical Exchange News
  • Jan. 06, 2025, 19:16 UTC
  • 47
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Delinquent. New value: Normal.

Comment Full text

Invivyd Inc (IVVD)

  • Technical Exchange News
  • Jan. 06, 2025, 19:16 UTC
  • 48
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Neurosense Therapeutics Ltd (NRSN)

  • Technical Exchange News
  • Jan. 04, 2025, 02:40 UTC
  • 52
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Neurosense Therapeutics Ltd (NRSNW)

  • Technical Exchange News
  • Jan. 04, 2025, 02:40 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

IO Biotech Inc. (IOBT)

  • Technical Exchange News
  • Jan. 04, 2025, 02:40 UTC
  • 55
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Icecure Medical Ltd (ICCM)

  • Technical Exchange News
  • Jan. 04, 2025, 02:40 UTC
  • 54
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Neurosense Therapeutics Ltd (NRSN)

  • Technical Exchange News
  • Jan. 03, 2025, 18:45 UTC
  • 53
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Neurosense Therapeutics Ltd (NRSNW)

  • Technical Exchange News
  • Jan. 03, 2025, 18:45 UTC
  • 51
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 281
  • 282
  • 283
  • 284
  • 285
  • Next

Search

News categories

  • Technical Exchange News(10898)
  • Event(2315)
  • SEC News(190439)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124849)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin